68963-75-7 Usage
General Description
4,6-dichloro-2(2H)-Pyridinone is a chemical compound with the molecular formula C5H2Cl2NO. It is a white to light yellow crystalline solid that is primarily used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 4,6-dichloro-2(2H)-Pyridinone is also known for its biocidal and antimicrobial properties, making it suitable for use in disinfectants, sanitizers, and preservatives. 4,6-dichloro-2(2H)-Pyridinone is also used as a building block in the production of dyes, pigments, and other specialty chemicals. It is important to handle and use this compound with caution, as it is classified as an irritant to the skin, eyes, and respiratory system. Additionally, it may be harmful if ingested or inhaled, and should be stored and handled in accordance with relevant safety guidelines and regulations.
Check Digit Verification of cas no
The CAS Registry Mumber 68963-75-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,9,6 and 3 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 68963-75:
(7*6)+(6*8)+(5*9)+(4*6)+(3*3)+(2*7)+(1*5)=187
187 % 10 = 7
So 68963-75-7 is a valid CAS Registry Number.
68963-75-7Relevant articles and documents
8-Azabicyclo[3.2.1]octane derivatives
-
Page/Page column 11, (2008/06/13)
The present invention relates to a 8-azabicyclo[3.2.1]octane derivative of Formula I, wherein each of the substituents is given the definition as set forth in the specification and claims, or a pharmaceutically acceptable salt thereof or solvate thereof. The present invention also relates to a pharmaceutical composition comprising an 8-azabicyclo[3.2.1]octane derivative in admixture with one or more pharmaceutically acceptable auxiliaries and to the use of the 8-azabicyclo[3.2.1]octane derivative in therapy.
9-Azabicyclo[3.3.1]nonane derivatives
-
Page/Page column 14/1, (2010/11/27)
The present invention relates to a 9-azabicyclo[3.3.1]nonane derivative of formula I, wherein each of the substituents is given the definition as set forth in the specification and claims, or a pharmaceutically acceptable salt or solvate thereof. The invention also relates to pharmaceutical compositions comprising said 9-azabicyclo[3.3.1]nonane derivatives and to their use in therapy.